Pharma Journalist -

Pfizer Inc. and BioNTech SE announced the initiation of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for the approval of a booster…
Read More...

Provectus Algae (Provectus), an Australian biotechnology platform company specialising in the biomanufacturing of high-value compounds for a wide array of industries using microalgae,…
Read More...

FSD Pharma Inc. a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal psychedelics and medical cannabis, announces today it has…
Read More...

Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced a multi-target strategic collaboration and…
Read More...

FLEXcon Company, Inc., an innovator in adhesive coating and laminating, today announced the relaunch of its FLEXcon PHARMcal line of track and trace solutions featuring engineered films…
Read More...

AbbVie announced the European Commission (EC) approved RINVOQ (upadacitinib), an oral, selective and reversible JAK inhibitor, for the treatment of moderate to severe atopic dermatitis…
Read More...

Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical need and large public health burden, announced that its…
Read More...

InDex Pharmaceuticals Holding AB (publ) announced that the U.S. Food and Drug Administration (FDA) has given clearance to start the phase III clinical study CONCLUDE in the United…
Read More...

Pfizer Inc. and Trillium Therapeutics Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical stage…
Read More...

Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for COMIRNATY (COVID-19 Vaccine, mRNA) to prevent…
Read More...